Encompass Pharmaceutical Competitors and Similar CompaniesClear all

Encompass Pharmaceutical's competitors and similar companies include Marvecs, Uniphar Group, Ashfield Healthcare and Dishman Group.

	Encompass Pharmaceutical Encompass Pharmaceutical Services is a pharmaceutical company focusing on chemistry, quality, and validation.	Marvecs Marvecs is a company providing sales and marketing solutions for the pharmaceutical industry.	Uniphar Group Uniphar Group is a healthcare services company.	Ashfield Healthcare Ashfield Healthcare provides contract sales and service outsourcing (CSO) for the pharmaceutical industry.	Dishman Group Dishman Group is a provider of outsourcing services for the pharmaceutical industry.
Founding Date	Founding Date N/A	Founding Date 1999	Founding Date 1994	Founding Date 1997	Founding Date 1983
Type	Type Private	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Business Products & Services outsourcing pharma	Tags Business Products & Services digital marketing agency outsourcing pharma project management	Tags Business Products & Services distribution outsourcing pharma	Tags Business Products & Services Healthcare compliance outsourcing pharma	Tags Business Products & Services chemicals outsourcing pharma
Locations	Locations Peachtree Corners, US HQ	Locations Ulm, DE HQ	Locations Dublin, IE HQ Hayes, GB Ocean Springs, US	Locations Ashby-de-la-Zouch, GB HQ Wien, AT Zaventem, BE Pointe Claire, CA København, DK Espoo, FI Mannheim, DE see more	Locations Ahmedabad, IN HQ Ahmedabad, IN Mumbai, IN Kyoto, JP London, GB Middlesex, US
Employees	Employees N/A	Employees 903% increase	Employees 3,5007% increase	Employees 1,6321% decrease	Employees 943
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €3.1b (FY, 2025)	Revenue (est.) £44m (FY, 2020)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €2.6b (FY, 2025)	Cost of goods £22.5m (FY, 2020)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €493.7m (FY, 2025)	Gross profit £21.5m (FY, 2020)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income €51.1m (FY, 2025)	Net income £1.3m (FY, 2020)	Net income N/A